Earnings ·
Omnicell reported second quarter 2026 total revenues of $312 million, a 7% increase year-over-year
OMCLOmnicell, Inc.
Omnicell reported second quarter 2026 total revenues of $312 million, a 7% increase year-over-year. GAAP net income rose to $24 million ($0.52 per diluted share) from $6 million in the prior year period, while non-GAAP net income reached $44 million ($0.94 per diluted share). The company received $15 million in refunds for previously paid IEEPA tariffs. Omnicell updated its full year 2026 guidance, raising non-GAAP EBITDA to a range of $175 million-$185 million and non-GAAP EPS to $2.15-$2.30. The firm also announced the promotion of Nnamdi Njoku to President and Chief Operating Officer. Omnicell operates in the healthcare technology industry, providing autonomous medication management solutions.